Icl Israel Chemicals Stock Net Income
| ICL Stock | USD 4.14 0.09 2.13% |
ICL Israel Chemicals fundamentals help investors to digest information that contributes to ICL Israel's financial success or failures. It also enables traders to predict the movement of ICL Stock. The fundamental analysis module provides a way to measure ICL Israel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICL Israel stock.
| Last Reported | Projected for Next Year | ||
| Net Income | 657.2 M | 754.5 M | |
| Net Income Applicable To Common Shares | 2.5 B | 2.6 B | |
| Net Income From Continuing Ops | 945 M | 770.3 M | |
| Net Income Per Share | 0.50 | 0.43 | |
| Net Income Per E B T | 0.65 | 0.84 |
ICL | Net Income |
ICL Israel Chemicals Company Net Income Analysis
ICL Israel's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ICL Israel Net Income | 657.17 M |
Most of ICL Israel's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ICL Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for ICL Israel is extremely important. It helps to project a fair market value of ICL Stock properly, considering its historical fundamentals such as Net Income. Since ICL Israel's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICL Israel's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICL Israel's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
ICL Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, ICL Israel Chemicals reported net income of 657.17 M. This is 5560.74% lower than that of the Chemicals sector and 183.0% higher than that of the Materials industry. The net income for all United States stocks is 15.09% lower than that of the firm.
ICL Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in net income category among its peers.
ICL Israel ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICL Israel's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICL Israel's managers, analysts, and investors.Environmental | Governance | Social |
ICL Israel Institutional Holders
Institutional Holdings refers to the ownership stake in ICL Israel that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ICL Israel's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ICL Israel's value.| Shares | Ubs Asset Mgmt Americas Inc | 2024-03-31 | 0.0 | Clal Insurance Enterprises Holdings Ltd | 2024-03-31 | 0.0 | Rfp Financial Group Llc | 2024-03-31 | 0.0 | Northern Trust Corp | 2024-03-31 | 0.0 | Ameriprise Financial Inc | 2024-03-31 | 0.0 | V-square Quantitative Management | 2024-03-31 | 0.0 | Sumitomo Mitsui Trust Holdings Inc | 2024-03-31 | 0.0 | Ifp Advisors, Llc | 2024-03-31 | 0.0 | Arlington Trust Co Llc | 2024-03-31 | 0.0 |
ICL Fundamentals
| Return On Equity | 0.081 | ||||
| Return On Asset | 0.0426 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 7.44 B | ||||
| Shares Outstanding | 1.29 B | ||||
| Shares Owned By Insiders | 44.05 % | ||||
| Shares Owned By Institutions | 26.10 % | ||||
| Number Of Shares Shorted | 1 M | ||||
| Price To Earning | 918.89 X | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 0.76 X | ||||
| Revenue | 7.65 B | ||||
| Gross Profit | 5.03 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 657.17 M | ||||
| Cash And Equivalents | 516 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 2.66 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | 4.46 X | ||||
| Cash Flow From Operations | 1.62 B | ||||
| Short Ratio | 1.00 X | ||||
| Earnings Per Share | 0.33 X | ||||
| Price To Earnings To Growth | 9.44 X | ||||
| Target Price | 4.74 | ||||
| Number Of Employees | 12 K | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 5.38 B | ||||
| Total Asset | 11.53 B | ||||
| Retained Earnings | 5.54 B | ||||
| Working Capital | 1.4 B | ||||
| Current Asset | 2.98 B | ||||
| Current Liabilities | 2.05 B | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 3.55 % | ||||
| Net Asset | 11.53 B | ||||
| Last Dividend Paid | 0.2 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ICL Israel Piotroski F Score and ICL Israel Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Dividend Share 0.201 | Earnings Share 0.33 | Revenue Per Share 5.458 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.